Atara Biotherapeutics, Inc.
NASDAQ: ATRA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Anhco Nguyen
- Employees
- 153
- Headquarters
- South San Francisco, United States
- IPO year
- 2014
- Market cap
- $95.1M
- Website
- https://www.atarabio.com
Loading ATRA…
Loading profile data…Frequently asked questions about ATRA
What does Atara Biotherapeutics, Inc. (ATRA) do?
Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candida...
Where does ATRA trade?
Atara Biotherapeutics, Inc. (ATRA) trades on the NASDAQ Global Select.
What sector is ATRA in?
Atara Biotherapeutics, Inc. (ATRA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Atara Biotherapeutics, Inc.?
Anhco Nguyen is the chief executive officer of Atara Biotherapeutics, Inc. (ATRA).
Where is Atara Biotherapeutics, Inc. headquartered?
Atara Biotherapeutics, Inc. is headquartered in United States.
Does ATRA pay a dividend?
Atara Biotherapeutics, Inc. (ATRA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATRA go public?
Atara Biotherapeutics, Inc. (ATRA) completed its initial public offering in 2014.